Dendritic cell based tumor vaccines
- 15 September 2000
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 74 (1) , 5-10
- https://doi.org/10.1016/s0165-2478(00)00243-1
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Tumor ImmunologyImmunity, 1998
- Effect of interleukin‐10 on dendritic cell maturation and functionEuropean Journal of Immunology, 1997
- The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-LigandThe Journal of Experimental Medicine, 1997
- Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.Proceedings of the National Academy of Sciences, 1996
- Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.The Journal of Experimental Medicine, 1996
- Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.The Journal of Experimental Medicine, 1996
- Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivoEuropean Journal of Immunology, 1994
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989